Kinomic profiling approach identifies Trk as a novel radiation modulator. 2012

John S Jarboe, and Jerry J Jaboin, and Joshua C Anderson, and Somaira Nowsheen, and Jennifer A Stanley, and Faris Naji, and Rob Ruijtenbeek, and Tianxiang Tu, and Dennis E Hallahan, and Eddy S Yang, and James A Bonner, and Christopher D Willey
Department of Biochemistry and Molecular Genetics, The University of Alabama at Birmingham, Birmingham, AL 35249-6832, USA.

BACKGROUND Ionizing radiation treatment is used in over half of all cancer patients, thus determining the mechanisms of response or resistance is critical for the development of novel treatment approaches. METHODS In this report, we utilize a high-content peptide array platform that performs multiplex kinase assays with real-time kinetic readout to investigate the mechanism of radiation response in vascular endothelial cells. We applied this technology to irradiated human umbilical vein endothelial cells (HUVEC). RESULTS We identified 49 specific tyrosine phosphopeptides that were differentially affected by irradiation over a time course of 1h. In one example, the Tropomyosin receptor kinase (Trk) family members, TrkA and TrkB, showed transient activation between 2 and 15 min following irradiation. When we targeted TrkA and TrkB using small molecule inhibitors, HUVEC were protected from radiation damage. Conversely, stimulation of TrkA using gambogic amide promoted radiation enhancement. CONCLUSIONS Thus, we show that our approach not only can identify rapid changes in kinase activity but also identify novel targets such as TrkA. TrkA inhibition resulted in radioprotection that correlated with enhanced repair of radiation-induced damage while TrkA stimulation by gambogic amide produced radiation sensitization.

UI MeSH Term Description Entries
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011494 Protein Kinases A family of enzymes that catalyze the conversion of ATP and a protein to ADP and a phosphoprotein. Protein Kinase,Kinase, Protein,Kinases, Protein
D011829 Radiation Dosage The amount of radiation energy that is deposited in a unit mass of material, such as tissues of plants or animal. In RADIOTHERAPY, radiation dosage is expressed in gray units (Gy). In RADIOLOGIC HEALTH, the dosage is expressed by the product of absorbed dose (Gy) and quality factor (a function of linear energy transfer), and is called radiation dose equivalent in sievert units (Sv). Sievert Units,Dosage, Radiation,Gray Units,Gy Radiation,Sv Radiation Dose Equivalent,Dosages, Radiation,Radiation Dosages,Units, Gray,Units, Sievert
D011836 Radiation Tolerance The ability of some cells or tissues to survive lethal doses of IONIZING RADIATION. Tolerance depends on the species, cell type, and physical and chemical variables, including RADIATION-PROTECTIVE AGENTS and RADIATION-SENSITIZING AGENTS. Radiation Sensitivity,Radiosensitivity,Sensitivity, Radiation,Tolerance, Radiation,Radiation Sensitivities,Radiation Tolerances,Radiosensitivities,Sensitivities, Radiation,Tolerances, Radiation
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

John S Jarboe, and Jerry J Jaboin, and Joshua C Anderson, and Somaira Nowsheen, and Jennifer A Stanley, and Faris Naji, and Rob Ruijtenbeek, and Tianxiang Tu, and Dennis E Hallahan, and Eddy S Yang, and James A Bonner, and Christopher D Willey
April 2017, Oncotarget,
John S Jarboe, and Jerry J Jaboin, and Joshua C Anderson, and Somaira Nowsheen, and Jennifer A Stanley, and Faris Naji, and Rob Ruijtenbeek, and Tianxiang Tu, and Dennis E Hallahan, and Eddy S Yang, and James A Bonner, and Christopher D Willey
January 2014, PloS one,
John S Jarboe, and Jerry J Jaboin, and Joshua C Anderson, and Somaira Nowsheen, and Jennifer A Stanley, and Faris Naji, and Rob Ruijtenbeek, and Tianxiang Tu, and Dennis E Hallahan, and Eddy S Yang, and James A Bonner, and Christopher D Willey
October 2016, Neurobiology of aging,
John S Jarboe, and Jerry J Jaboin, and Joshua C Anderson, and Somaira Nowsheen, and Jennifer A Stanley, and Faris Naji, and Rob Ruijtenbeek, and Tianxiang Tu, and Dennis E Hallahan, and Eddy S Yang, and James A Bonner, and Christopher D Willey
March 2022, European journal of immunology,
John S Jarboe, and Jerry J Jaboin, and Joshua C Anderson, and Somaira Nowsheen, and Jennifer A Stanley, and Faris Naji, and Rob Ruijtenbeek, and Tianxiang Tu, and Dennis E Hallahan, and Eddy S Yang, and James A Bonner, and Christopher D Willey
January 2016, PloS one,
John S Jarboe, and Jerry J Jaboin, and Joshua C Anderson, and Somaira Nowsheen, and Jennifer A Stanley, and Faris Naji, and Rob Ruijtenbeek, and Tianxiang Tu, and Dennis E Hallahan, and Eddy S Yang, and James A Bonner, and Christopher D Willey
May 2014, Oncogene,
John S Jarboe, and Jerry J Jaboin, and Joshua C Anderson, and Somaira Nowsheen, and Jennifer A Stanley, and Faris Naji, and Rob Ruijtenbeek, and Tianxiang Tu, and Dennis E Hallahan, and Eddy S Yang, and James A Bonner, and Christopher D Willey
January 2018, Biomarker research,
John S Jarboe, and Jerry J Jaboin, and Joshua C Anderson, and Somaira Nowsheen, and Jennifer A Stanley, and Faris Naji, and Rob Ruijtenbeek, and Tianxiang Tu, and Dennis E Hallahan, and Eddy S Yang, and James A Bonner, and Christopher D Willey
August 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,
John S Jarboe, and Jerry J Jaboin, and Joshua C Anderson, and Somaira Nowsheen, and Jennifer A Stanley, and Faris Naji, and Rob Ruijtenbeek, and Tianxiang Tu, and Dennis E Hallahan, and Eddy S Yang, and James A Bonner, and Christopher D Willey
April 2012, Atherosclerosis,
John S Jarboe, and Jerry J Jaboin, and Joshua C Anderson, and Somaira Nowsheen, and Jennifer A Stanley, and Faris Naji, and Rob Ruijtenbeek, and Tianxiang Tu, and Dennis E Hallahan, and Eddy S Yang, and James A Bonner, and Christopher D Willey
March 2017, Scientific reports,
Copied contents to your clipboard!